Neoplasms Pancreatic Clinical Trials

ReadTheTrial indexes 1 studies for Neoplasms Pancreatic. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Neoplasms Pancreatic.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Neoplasms Pancreatic

A Phase I/II, Open-Label Study to Investigate the Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics of GSK3145095 Administered Alone and in Combination With Anticancer Agents Including Pembrolizumab in Adult Participants With Selected Advanced Solid Tumors

NCT03681951 · TERMINATED · Phase 2

Frequently Asked Questions

What clinical trials are available for Neoplasms Pancreatic?

There are 1 clinical trials listed for Neoplasms Pancreatic. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Neoplasms Pancreatic trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Neoplasms Pancreatic trials in?

Current Neoplasms Pancreatic trials are distributed across: Phase 2 (1).

Find More Trials